The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Evolent Health Inc (NYSE: EVH) closed the day trading at $26.96 down -1.14% from the previous closing price of $27.27. In other words, the price has decreased by -$1.14 from its previous closing price. On the day, 1.63 million shares were traded. EVH stock price reached its highest trading level at $27.41 during the session, while it also had its lowest trading level at $26.84.
Ratios:
For a better understanding of EVH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 15.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.52. For the most recent quarter (mrq), Quick Ratio is recorded 1.01 and its Current Ratio is at 1.01. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.76.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on April 22, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On March 01, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $45.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $39.Barclays initiated its Overweight rating on January 03, 2024, with a $39 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 05 ’23 when Blackley Seth sold 141,000 shares for $26.54 per share. The transaction valued at 3,741,475 led to the insider holds 637,645 shares of the business.
McCarthy Daniel Joseph sold 11,000 shares of EVH for $330,000 on Nov 15 ’23. The PRESIDENT now owns 198,333 shares after completing the transaction at $30.00 per share. On Aug 15 ’23, another insider, Rafferty Emily Ann, who serves as the Chief Operating Officer of the company, sold 7,900 shares for $28.05 each. As a result, the insider received 221,595 and left with 70,897 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EVH now has a Market Capitalization of 3132724992 and an Enterprise Value of 3736247040. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.60 while its Price-to-Book (P/B) ratio in mrq is 2.88. Its current Enterprise Value per Revenue stands at 1.902 whereas that against EBITDA is 29.305.
Stock Price History:
Over the past 52 weeks, EVH has reached a high of $35.83, while it has fallen to a 52-week low of $23.33. The 50-Day Moving Average of the stock is -13.14%, while the 200-Day Moving Average is calculated to be -7.83%.
Shares Statistics:
Over the past 3-months, EVH traded about 944.27K shares per day on average, while over the past 10 days, EVH traded about 916810 shares per day. A total of 113.89M shares are outstanding, with a floating share count of 110.27M. Insiders hold about 5.10% of the company’s shares, while institutions hold 109.55% stake in the company. Shares short for EVH as of 1713139200 were 11382023 with a Short Ratio of 12.05, compared to 1710460800 on 10809465. Therefore, it implies a Short% of Shares Outstanding of 11382023 and a Short% of Float of 11.1499995.
